drugset / Trial / NCT04739592
A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis
Phase 4
Unknown
60 enrolled
Peking Union Medical College Hospital
CSPC Ouyi Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect of alendronate sodium vitamin D3 tablets compared with placebo on the improvement of joint structure and joint pain in participants with knee osteoarthritis. The treatment period of this study is one year and followed-up period is 2 years. The results of knee joint MRI will be evaluated by using the WORMS score.
Timeline
- Start
- 2021-07-07
- Primary completion
- 2023-07
- Completion
- 2024-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | — |
| Subject | Cholecalciferol | Other / unclassified | — | — |